UNSPSC 51124101: Adenosine

This classification denotes a nucleoside with the molecular formula C10H13N5O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) K72T3FS567, chemically known as 9h-purin-6-amine, 9-beta-d-xylofuranosyl- (9ci) but more generally known as adenosine, which bears US NIH Compound Identifier 191.

Adenosine comes in many forms, including arabinose, arabinoside-5-phosphate, cyclic 3,5-phosphate, dialdehyde, diphosphate, diphosphoglucose, diphosphopyridoxal, diphosphoribose, diphosphoric acid, monophosphofluoridate, oxide, phosphate, phosphonoacetic acid, phosphosulfate, sulfatophosphate, tetraphosphate, tetraphosphate pyridoxal, thiamine triphosphate, and triphosphate. European Medicines Agency schedules Adenosine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00297MIG.

UNSPSC 51124101 Adenosine is a Commodity code representing emergency pharmaceutical supply procurement by state and local health agencies, fire rescue services, and cooperative purchasing coalitions. State and local governments buy adenosine under this code as a critical advanced life support medication for emergency medical response, typically in standard formulations (6mg vials) bundled with other cardiac-support drugs such as epinephrine, labetalol, and diltiazem. Issuing bodies include municipal fire rescue departments, state health and human services commissions, and multistate cooperative purchasing alliances sourcing medications for participating state agencies and local government facilities. The procurement mix spans sealed-bid contracts for direct medication supply to emergency response units, Request for Information phases exploring direct-to-manufacturer pharmacy initiatives, and cooperative purchasing RFPs establishing framework agreements for generic pharmaceuticals distributed through authorized wholesalers to multiple jurisdictions.

Recent activity centers on Florida, Texas, and Minnesota. The City of Tampa's Purchasing Department issued IFB 26P00188 (response due April 8, 2026) for Advanced Life Support Medications including 330 units of Adenosine 6mg vials, with an estimated contract value of $40,000, firm pricing including freight to Tampa, nine-month minimum expiration dating, and a one-year term with two optional renewals and three additional 30-day unilateral extensions; the solicitation includes a 5 percent bid discount for Small Local Business Enterprise participation. Texas Health and Human Services Commission posted RFI HHS0017013 (due April 3, 2026) to assess vendor capacity for direct-to-manufacturer pharmaceutical contracting outside traditional pharmacy benefit manager arrangements, informing a subsequent formal RFP. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) administered by the Minnesota Department of Administration issued RFP S1070000015802 (due March 26, 2026) establishing multiple contracts for generic multi-source pharmaceuticals and OTC products effective July 1, 2026, distributed through AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co. to participating state and local government facilities in Minnesota and Oregon.